RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Tarun Mandal to Humans

This is a "connection" page, showing publications Tarun Mandal has written about Humans.
Connection Strength

0.292
  1. Kundu AK, Iyer SV, Chandra S, Adhikari AS, Iwakuma T, Mandal TK. Novel siRNA formulation to effectively knockdown mutant p53 in osteosarcoma. PLoS One. 2017; 12(6):e0179168.
    View in: PubMed
    Score: 0.028
  2. Ledet G, Graves RA, Bostanian LA, Mandal TK. A second-generation inhaled insulin for diabetes mellitus. Am J Health Syst Pharm. 2015 Jul 15; 72(14):1181-7.
    View in: PubMed
    Score: 0.025
  3. Graves RA, Ledet GA, Glotser EY, Mitchner DM, Bostanian LA, Mandal TK. Formulation and evaluation of biodegradable nanoparticles for the oral delivery of fenretinide. Eur J Pharm Sci. 2015 Aug 30; 76:1-9.
    View in: PubMed
    Score: 0.024
  4. Paira TK, Saha A, Banerjee S, Das T, Das P, Jana NR, Mandal TK. Fluorescent amphiphilic PEG-peptide-PEG triblock conjugate micelles for cell imaging. Macromol Biosci. 2014 Jul; 14(7):929-35.
    View in: PubMed
    Score: 0.022
  5. Kundu AK, Chandra PK, Hazari S, Ledet G, Pramar YV, Dash S, Mandal TK. Stability of lyophilized siRNA nanosome formulations. Int J Pharm. 2012 Feb 28; 423(2):525-34.
    View in: PubMed
    Score: 0.019
  6. Kundu AK, Chandra PK, Hazari S, Pramar YV, Dash S, Mandal TK. Development and optimization of nanosomal formulations for siRNA delivery to the liver. Eur J Pharm Biopharm. 2012 Feb; 80(2):257-67.
    View in: PubMed
    Score: 0.019
  7. Praetorius NP, Mandal TK. Alternate delivery route for amifostine as a radio-/chemo-protecting agent. J Pharm Pharmacol. 2008 Jul; 60(7):809-15.
    View in: PubMed
    Score: 0.015
  8. Praetorius NP, Mandal TK. Engineered nanoparticles in cancer therapy. Recent Pat Drug Deliv Formul. 2007; 1(1):37-51.
    View in: PubMed
    Score: 0.014
  9. Mandal TK. Inhaled insulin for diabetes mellitus. Am J Health Syst Pharm. 2005 Jul 01; 62(13):1359-64.
    View in: PubMed
    Score: 0.012
  10. Pramar YV, Mandal TK, Bostanian LA, Kader C, Morris TC, Graves RA. Physiochemical and Microbiological Stability of Azathioprine Suspensions in PCCA Base, SuspendIt. Int J Pharm Compd. 2023 Jul-Aug; 27(4):330-339.
    View in: PubMed
    Score: 0.011
  11. Pramar YV, Mandal TK, Bostanian LA, Kader C, Morris TC, Graves RA. Physicochemical and Microbiological Stability of Amitriptyline Hydrochloride Oral Liquid Dosage Forms in PCCA Base, SuspendIt. Int J Pharm Compd. 2022 Jul-Aug; 26(4):342-351.
    View in: PubMed
    Score: 0.010
  12. Pramar YV, Mandal TK, Bostanian LA, Kader C, Morris TC, Graves RA. Physicochemical and Microbiological Stability of Extemporaneously Compounded Hydrocortisone Oral Suspensions in PCCA Base, SuspendIt. Int J Pharm Compd. 2021 Sep-Oct; 25(5):431-439.
    View in: PubMed
    Score: 0.009
  13. Pramar YV, Mandal TK, Bostanian LA, Le G, Morris TC, Graves RA. Physicochemical and Microbiological Stability of Compounded Metronidazole Suspensions in PCCA SuspendIt. Int J Pharm Compd. 2021 Mar-Apr; 25(2):169-175.
    View in: PubMed
    Score: 0.009
  14. Pramar YV, Mandal TK, Bostanian LA, Le G, Morris TC, Graves RA. Physicochemical Stability of Compounded Allopurinol Suspensions in PCCA Base, SuspendIt. Int J Pharm Compd. 2020 Sep-Oct; 24(5):413-419.
    View in: PubMed
    Score: 0.009
  15. Chowdhury N, Chaudhry S, Hall N, Olverson G, Zhang QJ, Mandal T, Dash S, Kundu A. Targeted Delivery of Doxorubicin Liposomes for Her-2+ Breast Cancer Treatment. AAPS PharmSciTech. 2020 Jul 21; 21(6):202.
    View in: PubMed
    Score: 0.009
  16. Graves RA, Mandal TK, Bostanian LA, Nguyen AT, Swopes D, Morris TC, Pramar YV. Physicochemical Stability of Compounded Amlodipine Besylate Suspensions in PCCA Base, SuspendIt. Int J Pharm Compd. 2019 Nov-Dec; 23(6):519-527.
    View in: PubMed
    Score: 0.008
  17. Mandal TK. Development of biodegradable drug delivery system to treat addiction. Drug Dev Ind Pharm. 1999 Jun; 25(6):773-9.
    View in: PubMed
    Score: 0.008
  18. Pramar YV, Mandal TK, Bostanian LA, Nguyen AT, Morris TC, Graves RA. Physicochemical Stability of Compounded Naltrexone Hydrochloride Solutions in PCCA Base SuspendIt. Int J Pharm Compd. 2019 Mar-Apr; 23(2):157-162.
    View in: PubMed
    Score: 0.008
  19. Pramar YV, Mandal TK, Bostanian LA, Nguyen AT, Miller V, Morris TC, Graves RA. Stability of Compounded Ursodiol Suspensions in PCCA Base, SuspendIt. Int J Pharm Compd. 2019 Jan-Feb; 23(1):70-76.
    View in: PubMed
    Score: 0.008
  20. Mandal TK. Effect of solvent on the characteristics of pentamidine loaded microcapsule. J Biomater Sci Polym Ed. 1999; 10(1):1-17.
    View in: PubMed
    Score: 0.008
  21. Powell D, Chandra S, Dodson K, Shaheen F, Wiltz K, Ireland S, Syed M, Dash S, Wiese T, Mandal T, Kundu A. Aptamer-functionalized hybrid nanoparticle for the treatment of breast cancer. Eur J Pharm Biopharm. 2017 May; 114:108-118.
    View in: PubMed
    Score: 0.007
  22. Ledet GA, Graves RA, Glotser EY, Mandal TK, Bostanian LA. Preparation and in vitro evaluation of hydrophilic fenretinide nanoparticles. Int J Pharm. 2015 Feb 20; 479(2):329-37.
    View in: PubMed
    Score: 0.006
  23. Bhattacharjee PS, Huq TS, Mandal TK, Graves RA, Muniruzzaman S, Clement C, McFerrin HE, Hill JM. A novel peptide derived from human apolipoprotein E is an inhibitor of tumor growth and ocular angiogenesis. PLoS One. 2011 Jan 06; 6(1):e15905.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support